BlackRock Group’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-4,727
Closed -$73K 2804
2014
Q1
$73K Buy
+4,727
New +$73K ﹤0.01% 2576